Pharma’s omnichannel efforts have too often been piecemeal, producing short-term wins but limited long-term impact. To truly reach omnichannel maturity, commercial leaders must prove ROI, avoid fragmented investments, and make the case for sustained infrastructure that drives measurable business value. This panel explores how to move from campaigns to scalable platforms that deliver real returns.

• Building financial models that connect omnichannel investments directly to revenue growth and efficiency gains
• Investing in infrastructure and shifting funding from one-off initiatives toward scalable platforms that deliver long-term value
• Breaking down silos to prioritize investments that support both patient engagement and sustainable business outcomes
• Analyzing fragmented omni investments to identify what to stop doing and how to reinvest smarter